Initiates Coverage on ContraFect (NASDAQ:CFRX) initiated coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research report released on Monday morning. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Stock Up 9.7 % CFRX opened at $0.07 on Monday. The firm’s 50 day moving average is $0.35 and its 200-day moving average is […]

Leave a Reply

Your email address will not be published.

Previous post Adam Sandler mines his childhood for ‘Leo’
Next post PFSweb (NASDAQ:PFSW) Research Coverage Started at